Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome, March 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 76 articles:
HTML format


 

Single Articles

  1. JI L, Zhao X, Zhang Y, Zhao P, et al
    Efficacy and safety of Qinghua Zhixie Decoction against diarrhea-predominate irritable bowel syndrome: A protocol for a randomized controlled trial.
    Medicine (Baltimore). 2022;101:e28895.
    PubMed    
    Abstract available

  2. RUSSO F, Riezzo G, Linsalata M, Orlando A, et al
    Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study.
    Front Nutr. 2022;9:797192.
    PubMed    
    Abstract available

  3. REJ A, Sanders DS, Shaw CC, Buckle R, et al
    Efficacy and Acceptability of Dietary Therapies in Non-Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the Low FODMAP Diet and the Gluten-Free Diet.
    Clin Gastroenterol Hepatol. 2022 Feb 28. pii: S1542-3565(22)00202.
    PubMed    
    Abstract available

  4. NOBLE H, Hasan SS, Whorwell PJ, Vasant DH, et al
    The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID-19 pandemic.
    Neurogastroenterol Motil. 2022 Mar 3:e14347. doi: 10.1111/nmo.14347.
    PubMed    
    Abstract available

  5. LEE JY, Kim N, Yoon H, Shin CM, et al
    A Randomized, Double-Blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of DA-9701 (Motilitone) in Patients With Functional Dyspepsia and Constipation-type Irritable Bowel Syndrome Overlap: A Pilot Study.
    J Neurogastroenterol Motil. 2022 Mar 2. pii: jnm20236. doi: 10.5056/jnm20236.
    PubMed    
    Abstract available

  6. STROZYK A, Horvath A, Szajewska H
    FODMAP dietary restrictions in the management of children with functional abdominal pain disorders: A systematic review.
    Neurogastroenterol Motil. 2022 Mar 1:e14345. doi: 10.1111/nmo.14345.
    PubMed    
    Abstract available

  7. BAO C, Wu L, Shi Y, Shi Z, et al
    Long-term effect of moxibustion on irritable bowel syndrome with diarrhea: a randomized clinical trial.
    Therap Adv Gastroenterol. 2022;15:17562848221075131.
    PubMed    
    Abstract available

  8. EL-HAGGAR SM, Hegazy SK, Abd-Elsalam SM, Elkaeed EB, et al
    A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial.
    J Inflamm Res. 2022;15:1159-1172.
    PubMed    
    Abstract available

  9. GARCIA-RODRIGUEZ F, Raygoza-Cortez K, Moreno-Hernandez L, Garcia-Perez R, et al
    Outcomes of transitional care programs on adolescent chronic inflammatory systemic diseases: systematic review and meta-analyses.
    Pediatr Rheumatol Online J. 2022;20:15.
    PubMed    
    Abstract available

  10. KALUZNA M, Kompf P, Wachowiak-Ochmanska K, Moczko J, et al
    Are patients with polycystic ovary syndrome more prone to irritable bowel syndrome?
    Endocr Connect. 2022 Mar 1. pii: EC-21-0309. doi: 10.1530/EC-21-0309.
    PubMed    
    Abstract available

  11. BAVANI NG, Hajhashemy Z, Saneei P, Keshteli AH, et al
    The relationship between meal regularity with Irritable Bowel Syndrome (IBS) in adults.
    Eur J Clin Nutr. 2022 Mar 10. pii: 10.1038/s41430-022-01108.
    PubMed    
    Abstract available

  12. VERGNOLLE N
    Abdominal pain in irritable bowel syndrome.
    Nat Rev Gastroenterol Hepatol. 2022 Mar 10. pii: 10.1038/s41575-022-00599.
    PubMed    


  13. YACHHA SK, Sarma MS, Mohan N, Wadhwa N, et al
    Indian Academy of Pediatrics Consensus Guidelines for Probiotic Use in Childhood Diarrhea.
    Indian Pediatr. 2022 Mar 10. pii: S097475591600411.
    PubMed    
    Abstract available

  14. YANG PL, Matthews SW, Burr RL, Cain KC, et al
    Cognitive Behavioral Therapy-Based Comprehensive Self-Management Program Improves Presenteeism in Persons with Irritable Bowel Syndrome: A Secondary Data Analysis.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  15. MENDOZA-MARTINEZ VM, Zavala-Solares MR, Espinosa-Flores AJ, Leon-Barrera KL, et al
    Is a Non-Caloric Sweetener-Free Diet Good to Treat Functional Gastrointestinal Disorder Symptoms? A Randomized Controlled Trial.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  16. ELWING JE, Atassi H, Rogers BD, Sayuk GS, et al
    Emerging therapies in the management of Irritable Bowel Syndrome (IBS).
    Expert Opin Emerg Drugs. 2022 Mar 10. doi: 10.1080/14728214.2022.2052043.
    PubMed    
    Abstract available

  17. BAYER SB, Frampton CM, Gearry RB, Barbara G, et al
    Habitual Green Kiwifruit Consumption is Associated with a Reduction in Upper Gastrointestinal Symptoms - A Systematic Scoping Review.
    Adv Nutr. 2022 Mar 10. pii: 6546207. doi: 10.1093.
    PubMed    
    Abstract available

  18. SCHWILLE-KIUNTKE J, Ittermann T, Schmidt CO, Grabe HJ, et al
    Quality of life and sleep in individuals with irritable bowel syndrome according to different diagnostic criteria and inflammatory bowel diseases: A comparison using data from a population-based survey.
    Z Gastroenterol. 2022;60:299-309.
    PubMed    
    Abstract available

  19. CAPOZZA M, Laforgia N, Rizzo V, Salvatore S, et al
    Probiotics and Functional Gastrointestinal Disorders in Pediatric Age: A Narrative Review.
    Front Pediatr. 2022;10:805466.
    PubMed    
    Abstract available

  20. MARTIN A, Struble S, Prado A, Robinson J, et al
    A Case of Portal Vein Thrombosis in a Patient With Methylenetetrahydrofolate Reductase A1298C Polymorphism.
    Cureus. 2022;14:e21743.
    PubMed    
    Abstract available

  21. CHEN M, Ruan G, Chen L, Ying S, et al
    Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome.
    Front Endocrinol (Lausanne). 2022;13:817100.
    PubMed    
    Abstract available

  22. NUNEZ F P, Quera R, Bay C, Thomson P, et al
    Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases.
    Gastroenterol Hepatol. 2022;45:223-230.
    PubMed    
    Abstract available

  23. WU H, Zhan K, Rao K, Zheng H, et al
    Comparison of five diarrhea-predominant irritable bowel syndrome (IBS-D) rat models in the brain-gut-microbiota axis.
    Biomed Pharmacother. 2022;149:112811.
    PubMed    
    Abstract available

  24. EL-SALHY M, Mazzawi T, Hausken T, Hatlebakk JG, et al
    Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation.
    Neurogastroenterol Motil. 2022 Mar 18:e14353. doi: 10.1111/nmo.14353.
    PubMed    
    Abstract available

  25. SHEN J, Zhang B, Chen J, Cheng J, et al
    SAHA Alleviates Diarrhea-Predominant Irritable Bowel Syndrome Through Regulation of the p-STAT3/SERT/5-HT Signaling Pathway.
    J Inflamm Res. 2022;15:1745-1756.
    PubMed    
    Abstract available

  26. AGUILERA-LIZARRAGA J, Hussein H, Boeckxstaens GE
    Immune activation in irritable bowel syndrome: what is the evidence?
    Nat Rev Immunol. 2022 Mar 16. pii: 10.1038/s41577-022-00700.
    PubMed    
    Abstract available

  27. WU J, Lv L, Wang C
    Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials.
    Front Cell Infect Microbiol. 2022;12:827395.
    PubMed    
    Abstract available

  28. ESTUDILLO-GUERRA MA, Mesia-Toledo I, Schneider JC, Morales-Quezada L, et al
    The Use of Conditioning Open-Label Placebo in Opioid Dose Reduction: A Case Report and Literature Review.
    Front Pain Res (Lausanne). 2021;2:697475.
    PubMed    
    Abstract available

  29. BOONMA P, Shapiro JM, Hollister EB, Badu S, et al
    Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome.
    Front Pain Res (Lausanne). 2021;2:691689.
    PubMed    
    Abstract available

  30. WILLITS AB, Grossi V, Glidden NC, Hyams JS, et al
    Identification of a Pain-Specific Gene Expression Profile for Pediatric Recurrent Abdominal Pain.
    Front Pain Res (Lausanne). 2021;2:759634.
    PubMed    
    Abstract available

  31. KOECHLIN H, Kharko A, Probst T, Pradela J, et al
    Placebo Responses and Their Clinical Implications in Fibromyalgia: A Meta-Analysis Using SSRI and SNRI Trials.
    Front Pain Res (Lausanne). 2021;2:750523.
    PubMed    
    Abstract available

  32. WEAVER KR, Griffioen MA, Klinedinst NJ, Galik E, et al
    Quantitative Sensory Testing Across Chronic Pain Conditions and Use in Special Populations.
    Front Pain Res (Lausanne). 2022;2:779068.
    PubMed    
    Abstract available

  33. WANG RS, Lembo AJ, Kaptchuk TJ, Cheng V, et al
    Genomic Effects Associated With Response to Placebo Treatment in a Randomized Trial of Irritable Bowel Syndrome.
    Front Pain Res (Lausanne). 2022;2:775386.
    PubMed    
    Abstract available

  34. DE PALMA G, Bercik P
    Long-term personalized low FODMAP diet in IBS.
    Neurogastroenterol Motil. 2022 Mar 16:e14356. doi: 10.1111/nmo.14356.
    PubMed    
    Abstract available

  35. JONES MP, Shah A, Walker MM, Koloski NA, et al
    Overlap of heartburn, functional dyspepsia, and irritable bowel syndrome in a population sample: Prevalence, temporal stability, and associated comorbidities.
    Neurogastroenterol Motil. 2022 Mar 16:e14349. doi: 10.1111/nmo.14349.
    PubMed    
    Abstract available

  36. SANTUCCI NR, King C, El-Chammas KI, Wongteerasut A, et al
    Effect of percutaneous electrical nerve field stimulation on mechanosensitivity, sleep, and psychological comorbidities in adolescents with functional abdominal pain disorders.
    Neurogastroenterol Motil. 2022 Mar 16:e14358. doi: 10.1111/nmo.14358.
    PubMed    
    Abstract available

  37. FREUER D, Linseisen J, Meisinger C
    Asthma and the risk of gastrointestinal disorders: a Mendelian randomization study.
    BMC Med. 2022;20:82.
    PubMed    
    Abstract available

  38. SO D, Yao CK, Gibson PR, Muir JG, et al
    Evaluating tolerability of resistant starch 2, alone and in combination with minimally fermented fibre for patients with irritable bowel syndrome: a pilot randomised controlled cross-over trial.
    J Nutr Sci. 2022;11:e15.
    PubMed    
    Abstract available

  39. O'DRISCOLL S, Piggott C, Benton SC
    Evaluation of a faecal calprotectin method using the OC-SENSOR PLEDIA.
    Clin Chem Lab Med. 2022 Mar 14. pii: cclm-2022-0126. doi: 10.1515/cclm-2022-0126
    PubMed    
    Abstract available

  40. ALQAHTANI NH, Mahfouz MEM
    The Prevalence and Risk Factors of Irritable Bowel Syndrome in Saudi Arabia in 2019.
    Int J Prev Med. 2022;13:13.
    PubMed    
    Abstract available

  41. QIN D, Tao QF, Huang SL, Chen M, et al
    Eluxadoline Versus Antispasmodics in the Treatment of Irritable Bowel Syndrome: An Adjusted Indirect Treatment Comparison Meta-analysis.
    Front Pharmacol. 2022;13:757969.
    PubMed    
    Abstract available

  42. KATSUMI Y, Kodo K, Goto S
    Case Report: COVID-19 Pandemic Exacerbates Eating Disorder by Social and Intrafamilial Isolation.
    Front Pediatr. 2022;10:819214.
    PubMed    
    Abstract available

  43. KAUL I, Staggs VS, Bagherian A, Ali A, et al
    Pediatric Rome IV diagnosis agreement is greater than agreement on diagnostic testing.
    Neurogastroenterol Motil. 2022 Mar 13:e14355. doi: 10.1111/nmo.14355.
    PubMed    
    Abstract available

  44. HOJSAK I, Benninga MA, Hauser B, Kansu A, et al
    Benefits of dietary fibre for children in health and disease.
    Arch Dis Child. 2022 Mar 11. pii: archdischild-2021-323571.
    PubMed    
    Abstract available

  45. USAI-SATTA P, Lai M, Oppia F
    Lactose Malabsorption and Presumed Related Disorders: A Review of Current Evidence.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  46. GIACOSA A, Riva A, Petrangolini G, Allegrini P, et al
    Beneficial Effects on Abdominal Bloating with an Innovative Food-Grade Formulation of Curcuma longa and Boswellia serrata Extracts in Subjects with Irritable Bowel Syndrome and Small Bowel Dysbiosis.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  47. SIMOES CD, Maganinho M, Sousa AS
    FODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidence.
    Eur J Nutr. 2022;61:1187-1198.
    PubMed    
    Abstract available

  48. AWAD A, Madla CM, McCoubrey LE, Ferraro F, et al
    Clinical translation of advanced colonic drug delivery technologies.
    Adv Drug Deliv Rev. 2022;181:114076.
    PubMed    
    Abstract available

  49. MELGAARD D, Sorensen J, Riis J, Ovesen TS, et al
    Efficacy of FODMAP Elimination and Subsequent Blinded Placebo-Controlled Provocations in a Randomised Controlled Study in Patients with Ulcerative Colitis in Remission and Symptoms of Irritable Bowel Syndrome: A Feasibility Study.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  50. CURCI F, Corbo F, Clodoveo ML, Salvagno L, et al
    Polyphenols from Olive-Mill Wastewater and Biological Activity: Focus on Irritable Bowel Syndrome.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  51. SURYAWANSHI SS
    Gastrointestinal Health of People Working From Home Due to the COVID-19 Pandemic: Online, Cross-sectional Survey.
    Altern Ther Health Med. 2022 Mar 24. pii: AT7140.
    PubMed    
    Abstract available

  52. AGUILERA-LIZARRAGA J, Hussein H, Boeckxstaens GE
    Publisher Correction: Immune activation in irritable bowel syndrome: what is the evidence?
    Nat Rev Immunol. 2022 Mar 23. pii: 10.1038/s41577-022-00713.
    PubMed    


  53. SAADATI S, Sadeghi A, Mohaghegh-Shalmani H, Rostami-Nejad M, et al
    Effects of a gluten challenge in patients with irritable bowel syndrome: a randomized single-blind controlled clinical trial.
    Sci Rep. 2022;12:4960.
    PubMed    
    Abstract available

  54. BABAR AN, Hassan MK, Ullah F, Ullah A, et al
    Role of Lactobacillus plantarum 299v versus Placebo in symptomatic improvement of irritable bowel syndrome patients.
    J Pak Med Assoc. 2022;72:404-408.
    PubMed    
    Abstract available

  55. SABATE JM, Iglicki F
    Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome.
    World J Gastroenterol. 2022;28:732-744.
    PubMed    
    Abstract available

  56. LI R, Chen S, Gu X, An S, et al
    Role of the nuclear receptor subfamily 4a in mast cells in the development of irritable bowel syndrome.
    Comput Struct Biotechnol J. 2022;20:1198-1207.
    PubMed    
    Abstract available

  57. CHEN YM, Li Y, Wang X, Wang ZL, et al
    Effect of Bacillus subtilis, Enterococcus faecium, and Enterococcus faecalis supernatants on serotonin transporter expression in cells and tissues.
    World J Gastroenterol. 2022;28:532-546.
    PubMed    
    Abstract available

  58. CAETANO AC, Costa D, Silva-Mendes S, Correia-Pinto J, et al
    Constipation: Prevalence in the Portuguese community using Rome IV-Associated factors, toilet behaviours and healthcare seeking.
    United European Gastroenterol J. 2022 Mar 22. doi: 10.1002/ueg2.12221.
    PubMed    
    Abstract available

  59. HASLER WL, Grabauskas G, Singh P, Owyang C, et al
    Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome.
    Neurogastroenterol Motil. 2022 Mar 21:e14339. doi: 10.1111/nmo.14339.
    PubMed    
    Abstract available

  60. LIANG SB, Han M, Cheng HJ, Zhang QY, et al
    Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.
    Trials. 2022;23:226.
    PubMed    
    Abstract available

  61. GAO Y, Mei C, Chen P, Chen X, et al
    The contribution of neuro-immune crosstalk to pain in the peripheral nervous system and the spinal cord.
    Int Immunopharmacol. 2022;107:108700.
    PubMed    
    Abstract available

  62. IBRAHIM M, Ahmeid M
    Metformin effects on zonulin level in polycystic ovarian women.
    ADMET DMPK. 2022;9:49-55.
    PubMed    
    Abstract available

  63. WU X, Wang J, Ye Z, Wang J, et al
    Risk of Colorectal Cancer in Patients With Irritable Bowel Syndrome: A Meta-Analysis of Population-Based Observational Studies.
    Front Med (Lausanne). 2022;9:819122.
    PubMed    
    Abstract available

  64. COLOMIER E, Melchior C, Algera JP, Hreinsson JP, et al
    Global prevalence and burden of meal-related abdominal pain.
    BMC Med. 2022;20:71.
    PubMed    
    Abstract available

  65. FOX M
    Editorial: meal-induced symptoms in irritable bowel syndrome-"all in the mind"?
    Aliment Pharmacol Ther. 2022;55:880-881.
    PubMed    


  66. PIMENTEL M, Mathur R, Wang J, Chang C, et al
    A Smartphone Application Using Artificial Intelligence Is Superior to Subject Self-Reporting When Assessing Stool Form.
    Am J Gastroenterol. 2022 Mar 14. pii: 00000434-990000000-00275.
    PubMed    
    Abstract available

  67. RADZIWON CD, Quigley BM, Vargovich AM, Krasner SS, et al
    Do I really have to do my homework? The role of homework compliance in cognitive behavioral therapy for irritable bowel syndrome.
    Behav Res Ther. 2022;152:104063.
    PubMed    
    Abstract available

  68. LUKIC S, Mijac D, Filipovic B, Sokic-Milutinovic A, et al
    Chronic Abdominal Pain: Gastroenterologist Approach.
    Dig Dis. 2022;40:181-186.
    PubMed    
    Abstract available

  69. HUNGIN AP
    Chronic Constipation in Adults: The Primary Care Approach.
    Dig Dis. 2022;40:142-146.
    PubMed    
    Abstract available

  70. HASSANIN TM, Fouad Y, Mohamed FE, Abdel-Hafeez EH, et al
    Colonic mucosal eosinophilia and immunohistochemical expression of COX-2 and NF-kB in patients with irritable bowel syndrome.
    Eur J Gastroenterol Hepatol. 2022 Mar 10. pii: 00042737-900000000-97082.
    PubMed    
    Abstract available

  71. CHEY WD, Hashash JG, Manning L, Chang L, et al
    AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review.
    Gastroenterology. 2022 Mar 22. pii: S0016-5085(21)04084.
    PubMed    
    Abstract available

  72. ROTH B, Larsson E, Ohlsson B
    Poor intake of vitamins and minerals among patients with irritable bowel syndrome is associated with symptoms.
    J Gastroenterol Hepatol. 2022 Mar 18. doi: 10.1111/jgh.15830.
    PubMed    
    Abstract available

  73. STRISCIUGLIO C, Cenni S, Serra MR, Dolce P, et al
    Functional Gastrointestinal Disorders in Mediterranean Countries According to Rome IV Criteria.
    J Pediatr Gastroenterol Nutr. 2022;74:361-367.
    PubMed    
    Abstract available

  74. TOUNY AA, Kenny E, Mansson M, Webb DL, et al
    Pain relief and pain intensity response to GLP-1 receptor agonist ROSE-010 in irritable bowel syndrome; clinical study cross-analysis with respect to patient characteristics.
    Scand J Gastroenterol. 2022 Mar 2:1-9. doi: 10.1080/00365521.2022.2041084.
    PubMed    
    Abstract available

  75. WALLEN H, Ljotsson B, Svanborg C, Rydh S, et al
    Exposure based cognitive behavioral group therapy for IBS at a gastroenterological clinic - a clinical effectiveness study.
    Scand J Gastroenterol. 2022 Mar 9:1-8. doi: 10.1080/00365521.2022.2047220.
    PubMed    
    Abstract available

  76. PAGAN-BUSIGO JE, Lopez-Carrasquillo J, Appleyard CB, Torres-Reveron A, et al
    Beyond depression and anxiety; a systematic review about the role of corticotropin-releasing hormone antagonists in diseases of the pelvic and abdominal organs.
    PLoS One. 2022;17:e0264909.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;